Question 1

What is the catalog number for Human ANKRD18B activation kit by CRISPRa?

Accepted Answer

The catalog number for Human ANKRD18B activation kit by CRISPRa is GA118509.

Question 2

What sizes are available for Human ANKRD18B activation kit by CRISPRa?

Accepted Answer

Human ANKRD18B activation kit by CRISPRa is available in the following size(s): 1 Kit.

Question 3

Is Human ANKRD18B activation kit by CRISPRa in stock?

Accepted Answer

Human ANKRD18B activation kit by CRISPRa is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Where can I find the safety data sheet (SDS/MSDS) for Human ANKRD18B activation kit by CRISPRa?

Accepted Answer

The safety data sheet for Human ANKRD18B activation kit by CRISPRa is available here: https://cdn.origene.com/sds/ga118509.pdf.

Question 5

What is Human ANKRD18B activation kit by CRISPRa used for?

Accepted Answer

ANKRD18B CRISPRa kit - CRISPR gene activation of human ankyrin repeat domain 18B

Question 6

What is the recommended positive control for this assay?

Accepted Answer

A recommended positive control, where one is specified by the manufacturer, is listed on the datasheet or in the assay protocol.

Question 7

How should this product be stored?

Accepted Answer

Storage conditions depend on the specific reagent and are listed on the product datasheet, with most antibodies and proteins requiring -20°C unless stated otherwise. It is your responsibility to store the product correctly immediately upon receipt; damage from improper storage after delivery is not eligible for replacement.

Question 8

Is this product animal-origin-free?

Accepted Answer

Animal-origin-free status, where applicable, is noted on the datasheet under formulation details.

Human ANKRD18B activation kit by CRISPRa

Product Specifications

Gene Location

Symbol

Frequently Asked Questions

Explore Other Products

Fumonisin B2

Phthalimide-d4

Plasma/Serum Cell-Free Circulating DNA Purification Mini Kit

Multi-Well Plates

Cyclododecanone

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2745), 1mg/mL